Not available
Quote | GlaxoSmithKline PLC (NYSE:GSK)
Last: | $43.35 |
---|---|
Change Percent: | -0.78% |
Open: | $42.9 |
Close: | $43.35 |
High: | $43.515 |
Low: | $42.75 |
Volume: | 5,943,545 |
Last Trade Date Time: | 05/02/2024 03:00:00 am |
News | GlaxoSmithKline PLC (NYSE:GSK)
2024-05-02 13:48:51 ET More on Moderna Moderna, Inc. (MRNA) Q1 2024 Earnings Call Transcript Moderna, Inc. 2024 Q1 - Results - Earnings Call Presentation Moderna Investors Should Beware Patent-Dispute Fallout Moderna tops forecasts in Q1 despite COVID-related...
Enact Holdings Inc. (ACT) is expected to report $0.99 for Q1 2024 FormFactor Inc. (FORM) is expected to report $0.09 for Q1 2024 SAAB AB - Class B (SAABF) is expected to report for quarter end 2024-03-31 Lumos Pharma Inc. (LUMO) is expected to report $-1.21 for Q1 2024 Axis Capita...
Message Board Posts | GlaxoSmithKline PLC (NYSE:GSK)
Subject | By | Source | When |
---|---|---|---|
whytestocks: $GSK News Article - Global pharma giants partner Singapore researchers to boost innovat | whytestocks | investorshangout | 12/06/2022 7:20:45 PM |
whytestocks: $GSK News Article - Spero Therapeutics Announces Closing of Exclusive License Agreement | whytestocks | investorshangout | 11/08/2022 1:30:52 PM |
whytestocks: $GSK News Article - 3 Dirt-Cheap Stocks That Could Soar 48% to 68%, According to Wall S | whytestocks | investorshangout | 10/07/2022 3:15:49 PM |
Post hoc analysis shows that biomarker correlates with | jondoeuk | investorshub | 09/13/2022 4:41:37 PM |
$GSK Total Debt is $22.11 Billion // $8.00 | BottomBounce | investorshub | 08/11/2022 1:02:19 PM |
News, Short Squeeze, Breakout and More Instantly...
GlaxoSmithKline PLC Company Name:
GSK Stock Symbol:
NYSE Market:
Wednesday, GSK Plc (NYSE:GSK) reported first-quarter sales of $9.33 billion (7.4 billion Sterling Pounds), up 10% Y/Y and 13% e...
A negative sentiment might linger on Wall Street on Wednesday, as evidenced by stock futures, after Advanced Micro Devices, Inc.‘s (NASD...
Enact Holdings Inc. (ACT) is expected to report $0.99 for Q1 2024 FormFactor Inc. (FORM) is expected to report $0.09 for Q1 2024 SAAB AB - Class B (SAABF) is expected to report for quarter end 2024-03-31 Lumos Pharma Inc. (LUMO) is expected to report $-1.21 for Q1 2024 Axis Capita...